Study finds benefits listed in larger text than risks in mags

Share this article:
A study of oncology drug ads in the magazines CURE, Coping With Cancer and MAMM found benefits presented more prominently and in larger text than risks. The study, presented to the American Society of Clinical Oncology's annual meeting, found that while benefits usually placed in the top third of the ad space, risks were often presented in smaller type and relegated to the lower half of the page.
Share this article:

Email Newsletters

More in News

Astellas, DOJ settle for $7.3M

Astellas, DOJ settle for $7.3M

Astellas has settled a False Claims case with the Department of Justice over the 2010-2013 marketing of an antifungal medication. Astellas denies the allegations.

Boehringer drug lands US, EU orphan tag

Boehringer drug lands US, EU orphan tag

The experimental Breakthrough Therapy treatment is for acute myeloid leukemia.

Omnio app moves to smartphones

Omnio app moves to smartphones

Physicians Interactive is introducing the third wave of its Omnio app, making the tablet-only tool available for iPhones and Android phones.